YOKNEAM, Israel, Nov. 7, 2012 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, today announced third quarter 2012 financial results for the three month and nine month periods ended September 30, 2012.
(Logo: http://photos.prnewswire.com/prnh/20120528/535447 )
Third Quarter 2012 Year-Over-Year Financial Highlights Include:
- International revenue of $40.8 million, up 8%
- North America revenue of $19.3 million, up 1%
- EBU1 segment revenue of $6.9 million, up 37%
- Non-GAAP gross margin of 55.3%, up from 53.8%
- PAD2 segment non-GAAP operating margin of 9.1%
- Non-GAAP EPS of $0.03
- Cash and investments portfolio of $128.4 million at September 30, 2012
2012 YTD Year-Over-Year Financial Highlights Include:
- International revenue of $128.2 million up 16%
- North America revenue of $62.7 million, up 11%
- EBU segment revenue of $19.9 million, up 42%
- Non-GAAP gross margin of 54.7%, up from 53.8%, or 52.6% up from 50.7% on a GAAP basis
- PADsegment non-GAAP operating margin of 9.6%, or 3.7%
